13th edition

Format
HYBRID

December 3rd & 4th, 2024

IN-PERSON | LILLE, FR

December 11th& 12th 2024

ONLINE MEETINGS

Stand C3/7

2018 Edition

Antineo

France

Antineo accompanies clients in the preclinical development of novel anticancer agents. We provide strategic advice for preclinical development (choice of indications to focus on etc.), and expertise and in vitro, ex vivo and in vivo services aiming at characterising the mode of action and the anti-tumoral efficacy of new drugs.
We have a strong expertise in immunotherapies, and in the development and characterisation of original models for secondary resistances to gold standards.

Scroll to Top
  • No products in the cart.